This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Stanley Gibbons Group Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Belangrijke informatie
50.7%
Groei van de winst
74.5%
Groei van de winst per aandeel
Specialty Retail Groei van de industrie | 4.1% |
Inkomstengroei | -23.5% |
Rendement op eigen vermogen | n/a |
Nettomarge | -37.9% |
Laatste winstupdate | 30 Sep 2021 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Stanley Gibbons Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 21 | 11 | -4 | 7 | 0 |
30 Jun 21 | 11 | -4 | 7 | 0 |
31 Mar 21 | 11 | -4 | 7 | 0 |
31 Dec 20 | 11 | -3 | 7 | 0 |
30 Sep 20 | 11 | -3 | 7 | 0 |
30 Jun 20 | 12 | -3 | 8 | 0 |
31 Mar 20 | 13 | -2 | 8 | 0 |
31 Dec 19 | 13 | -3 | 9 | 0 |
30 Sep 19 | 13 | -3 | 9 | 0 |
30 Jun 19 | 13 | -3 | 9 | 0 |
31 Mar 19 | 12 | -4 | 10 | 0 |
30 Sep 18 | 11 | -7 | 10 | 0 |
30 Jun 18 | 12 | -8 | 11 | 0 |
31 Mar 18 | 13 | -8 | 11 | 0 |
30 Sep 17 | 5 | -8 | 7 | 0 |
30 Jun 17 | 10 | -10 | 10 | 0 |
31 Mar 17 | 15 | -11 | 14 | 0 |
31 Dec 16 | 43 | -32 | 26 | 0 |
30 Sep 16 | 47 | -35 | 27 | 0 |
30 Jun 16 | 53 | -32 | 28 | 0 |
31 Mar 16 | 59 | -28 | 28 | 0 |
31 Dec 15 | 61 | -15 | 28 | 0 |
30 Sep 15 | 62 | -2 | 27 | 0 |
Kwaliteitswinsten: TB6 is currently unprofitable.
Groeiende winstmarge: TB6 is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: TB6 is unprofitable, but has reduced losses over the past 5 years at a rate of 50.7% per year.
Versnelling van de groei: Unable to compare TB6's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: TB6 is unprofitable, making it difficult to compare its past year earnings growth to the Specialty Retail industry (-13.4%).
Rendement op eigen vermogen
Hoge ROE: TB6's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.